ERGi-USU-6 mesylate
Ref. TM-T61062
25mg | 1,005.00 € | ||
50mg | 1,312.00 € | ||
100mg | 2,099.00 € |
Product Information
ERGi-USU-6 (mesylate) is a new selective ERG positive prostate cancer inhibitor with an IC50 value of 0.089 μM that is an ERGi-USU-6 salt derivative.
Chemical properties
Technical inquiry about: TM-T61062 ERGi-USU-6 mesylate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.